Drug recall · May 18, 2016
Paliperidone Extended-release Tablets recall
Why: Failed Dissolution Specifications; three month stability time point.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Paliperidone Extended-release Tablets, 1.5 mg, 30 count bottles, Rx only, Mylan Pharmaceuticals, Inc., Morgantown, WV --- NDC 0378-3978-93
- Lots / codes
Lot: 2005441, 01/2017, Code: 0378-3978-93
- Quantity
- 2928 bottles
- Company
- Mylan Pharmaceuticals Inc., Morgantown, WV
- Distribution
- Nationwide
- Initiated
- February 12, 2016 · Voluntary: Firm initiated
- Classified
- May 6, 2016
- Reported
- May 18, 2016
- Ended
- October 26, 2016
- How notified
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Paliperidone
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.